Earlier studies in our laboratory showed that the lipopolysaccharide (LPS) In previous experiments designed to elucidate the immunoregulatory properties of endotoxin-associated protein (EP) and other polyclonal B-cell activators, we found that when lipopolysaccharide (LPS) was used in conjunction with these cell stimulators, activation of nonresponder C3H/HeJ splenic B lymphocytes was actually inhibited by the LPS (13). No evidence was found that the LPS stimulated suppressor T cells or macrophages of the C3HIIHeJ mouse, which would serve to shut off stimulated B-cell proliferation or polyclonal antibody synthesis by some means. Our working hypothesis, therefore, has been that the observed suppression was the result of a biochemical event(s) in C3H/HeJ
Earlier studies in our laboratory showed that the lipopolysaccharide (LPS) of SabnoneUla typhi, which fails to activate B lymphocytes of C3H/HeJ mice, can suppress proliferation and polyclonal antibody synthesis by these cells when they are stimulated by polyclonal activators. In order to determine what stage of the cell cycle was blocked, resting B cells from C3H/HeJ spleens were activated by using different mitogens in the presence of inhibitory concentrations of LPS and analyzed by flow cytometry, using acridine orange to stain DNA and RNA. LPS was found to inhibit the progression of cells into the Gl stage of the cell cycle. Furthermore, [3lHluridine uptake studies showed that RNA synthesis is inhibited during the early phase of activation. These results indicate that inhibition by LPS of the signalling process occurs during a critical period of the cell cycle when the cells become susceptible to the inhibitory effects of LPS. To examine whether LPS acts only on B cells or whether it can suppress other immunocompetent cells from C3H/HeJ mice, studies were carried out on activated thymocytes and macrophages. LPS was found to inhibit thymocyte proliferation stimulated by concanavalin A or the combination of phorbol myristate acetate and ionomycin. Prostaglandin E2 synthesis by macrophages was also blocked by LPS. Thus, LPS is a potent inhibitor of the functioning of the major immunocompetent cells of C3H/HeJ mice.
In previous experiments designed to elucidate the immunoregulatory properties of endotoxin-associated protein (EP) and other polyclonal B-cell activators, we found that when lipopolysaccharide (LPS) was used in conjunction with these cell stimulators, activation of nonresponder C3H/HeJ splenic B lymphocytes was actually inhibited by the LPS (13) . No evidence was found that the LPS stimulated suppressor T cells or macrophages of the C3HIIHeJ mouse, which would serve to shut off stimulated B-cell proliferation or polyclonal antibody synthesis by some means. Our working hypothesis, therefore, has been that the observed suppression was the result of a biochemical event(s) in C3H/HeJ B cells that resulted in the interruption of the normal signalling mechanism. The experiments described below are an extension of our original study and serve to emphasize that this suppressive phenomenon blocks progression of most of the EP-activated B cells through the cell cycle by inhibiting the cells from entering into the Gl phase. (18) , using as a starting material trichloroacetic acidextracted endotoxin from Salmonella typhi 0-901 (15) . Phenol extraction was conducted twice on the aqueous layer containing the LPS followed by ultracentrifugation of the LPS at 100,000 x g for 4 h to remove any contaminating nucleic acid. Amino acid analysis of the purified LPS was performed in the laboratory of Julie Rushbrook of our institution, using an Applied Biosystems 130A amino acid analyzer. The LPS typically contained less than 0.3% peptides. EP was prepared from S. typhi 0-901 as described earlier (15 Cell cycle analysis by cytofluorometry. The cell cycle analysis was done by measuring cellular RNA and DNA content, using acridine orange dye, by the method of Darzynkiewickz et al. (2) . Acridine orange binding to double-stranded DNA results in green (530-nm) fluorescence, while binding to single-stranded RNA gives red i>600-nm) fluorescence. Purified resting B cells (2.5 x 10 /ml) from C3HIHeJ mice were cultured in medium as described above with various mitogens and with or without LPS. At specific time intervals between 0 and 66 h, 1 ml of FCS was added to the culture. The cells were then fixed with 6 ml of 70% cold ethanol and kept at 4°C until analyzed. The flow cytometric analysis was done using an argon ion laser (388 nm) for excitation and measuring green and red fluorescence with a dilutions of the culture supernatants, acetylcholinesteraselabeled PGE2, and anti-PGE2 antibody. Plates were incubated overnight at room temperature and washed, and then a constant amount of acetylcholine derivative was added and the color was allowed to develop for 3 h. The color change was read at a 420-nm wavelength with a microtiter reader (ARTEK Systems Corp.), and PGE2 was estimated by using a standard curve that was prepared by using known amounts of pure PGE2.
Cytotoxicity assay. Cell viability was measured by vital dye staining with eosin Y. C3H/HeJ spleen cells or thymocytes were suspended at 2.5 x 106 cells per ml in culture medium. Cells were cultured with or without stimulants at the appropriate concentrations and LPS at 100 ,ug/ml. After 24 h of culture, 10 replicate cultures per group were pooled and the cells were centrifuged. The cell pellet was resuspended in 1 ml of medium, and 0.1 ml was added to an equal volume of a solution of 0.1% eosin Y in 3% FCS. In this manner, a sufficient number of cells were available to assess viability by direct counting in a hemocytometer chamber.
RESULTS
Suppression of DNA synthesis in activated B lymphocytes.
When resting B cells of C3H/HeJ mice are cultured in the presence of various concentrations of EP a dose response is obtained as shown in Fig. 1 . However, when various concentrations of LPS are added at the initiation of the culture in the presence of EP, suppression of DNA synthesis likewise occurs in a dose-dependent manner (Fig. 1) ered nor the viability of the cells so sampled differed significantly. In a representative example of not less than 200 cells counted, 56% of the cells were viable in the absence of stimulant or LPS whereas 54% of the cells exposed to 100 ,ug of LPS per ml and 57% of the cells exposed to both 5 ,ug of EP per ml and 100 ,g of LPS per ml were viable. In a similar manner, the viability of thymocytes was assayed, and likewise there were no significant differences between cells unexposed to LPS and those exposed (89 versus 87% viability, respectively).
Effect of LPS on PKC-mediated DNA synthesis. Recent work in our laboratory has shown that DNA and RNA synthesis stimulated by EP in C3H/HeJ B cells is mediated to a large extent by protein kinase C (PKC) activation (1).
Since the synergistic combination of PMA and the Ca2l ionophore ionomycin activates PKC and drives both B and T cells to synthesize DNA (1, 8) , we chose to determine whether LPS would affect PKC-mediated DNA synthesis in C3H/HeJ B cells. The results depicted in Fig. 2 show that the suppression of DNA synthesis in B cells stimulated by PMA and ionomycin (Fig. 2B) follows a pattern similar to that seen in EP-activated B cells (Fig. 2A) . When LPS is added at the initiation of the cell culture (O h), about 66% inhibition occurs in PKC-activated cells compared with approximately 70% inhibition in cells stimulated with EP. Substantial inhibition was observed (40 and 55%, respectively) when LPS was added to both types of cultures after 12 h of activation, indicating that some cells in the Gl phase of the cell cycle that were stimulated either by PMA and ionomycin or by EP may still be susceptible to the shutdown and therefore cannot enter the S phase.
LPS inhibition of B-cell progression through the cell cycle. In order to determine when in the cell cycle the inhibitory effect of LPS on B cells took place, we used cytofluorometry to assess the relative amounts of RNA and DNA per cell. By this method, we could establish the stage of the cell cycle through which the cells were progressing in the presence of the EP mitogen when they were blocked with LPS that was added at the initiation of the culture. As shown in Fig. 3 , resting B cells activated by EP show a steady increase in the percentage of cells in Gl beginning at 12 h; however, for cells exposed to LPS, inhibition of the percentage of cells entering the Gl phase was seen first at 12 h. This inhibition persisted at later time points, and as a consequence, fewer cells initiated DNA synthesis when exposed to LPS, as shown by the differences in the percentages of cells in the S phase (Fig. 3B) .
LPS suppression of RNA synthesis in B cells. To confirm the inhibitory effect of LPS on the progression of C3H/HeJ B cells through Gl, we measured RNA synthesis in EPactivated cells exposed to LPS. As shown in Table 1 LPS suppression of macrophage activation. Our previous studies (13, 14) have shown that certain R types of LPS, including the Salmonella minnesota R595 LPS (5), can stimulate to a limited degree the proliferation of B cells and interleukin-1 production by macrophages of C3HJHeJ mice. In order to determine whether the wild-type smooth LPS could inhibit C3H/HeJ macrophage activation, we employed a sensitive assay for the production of another macrophage product, PGE2. As shown in Fig. 4 , R595 LPS activated PGE2 production in C3H/HeJ macrophages in a dose-response fashion, with a maximum stimulation index of about 26 at 50 ,ug/ml. However, in the presence of a smooth Salmonella typhi LPS, PGE2 production stimulated by R595 LPS was strikingly reduced. Therefore, not only are the biochemical events associated with the proliferation of C3H/ HeJ B and T cells blocked by smooth LPS but the conversion of arachidonic acid to PGE2 in C3H/HeJ macrophages is also blocked. 
DISCUSSION
In our previous studies dealing with the phenomenon of LPS suppression of C3H/HeJ splenic B lymphocytes activated by protein mitogens, we found that these cells appeared most susceptible to inhibition when they were in an activated state (13) . However, the cell cultures consisted of a mixture of B cells, T cells, and macrophages, which suggested the possibility of accessory cells playing a role in the suppression observed. Consequently, T cells were depleted by using anti-Thy 1.2 antibody and complement. Reduction of the inhibitory effect was not observed in T-cell-depleted cultures, and in fact, the level of inhibition was enhanced as much as 30% when R595 LPS was used as a stimulant and smooth LPS from S. typhi 0-901 was used as an inhibitor (14) . Furthermore, triple adsorption with carbonyl iron to remove adherent macrophages from spleen cell suspensions also had no effect on the level of inhibition induced by S. typhi LPS (data not shown). Confirmation of these results has been obtained in the experiments reported here by the use of highly enriched resting B cells which were activated by EP and also inhibited by LPS, strongly suggesting that accessory cells are not involved in this inhibitory phenomenon but rather that the smooth LPS is acting directly on B cells. Depletion of these accessory cells did not alter the suppression effects of LPS, and in the experiments reported here, purified resting B cells activated by EP were also inhibited by LPS, thereby eliminating accessory T cells or macrophages as a factor.
This inhibition of B cells was clearly dose dependent, as depicted in Fig. 1 . Furthermore, the inhibition appeared not to be a function of whether the cells were cultured at a level of 2.5 x 105 cells per well or at 10-fold-higher-levels in tubes. However, fewer B cells required less LPS for inhibition, and if the activation was enhanced with higher concentrations of stimulant, less inhibition was observed with a constant amount of LPS, as shown by the data for activated thymocytes in Table 2 . Nevertheless, the amount of LPS used to suppress C3H/HeJ cells would activate normal LPS responder C3H/OuJ cells. Furthermore, the viability experiment with thymocytes and spleen cells showed no significant differences between cells exposed to a high concentration of LPS and those not exposed during a 24-h period prior to the time when activated cells would initiate DNA synthesis. Therefore, we conclude that the inhibition we have observed is probably not due to nonspecific cell death or disruption of cell membranes caused by LPS. In addition, this inhibition phenomenon is not restricted to S. typhi LPS since we have also observed similar levels of inhibition of splenic B-cell DNA synthesis with LPS from Escherichia coli 0127:B8 and Salmonella typhimurium (data not shown).
In contrast to our work, Flebbe et al. (4) reported that LPS from E. coli O111:B4 did not inhibit [3H]thymidine uptake in C3HIHeJ spleen cells stimulated by an Ra-LPS and Rd-LPS from S. minnesota. Their experiment, conducted in microtiter cell cultures, however, was limited to a single low dose of E. coli LPS with double the number of cells, compared with our culture system reported here, suggesting that less than optimal conditions were operative in their experiment.
In other instances an LPS precursor has been shown to inhibit the activation of proliferation of C3HIHeJ spleen cells. Tomai et al. (16) reported that lipid X and its monoacyl glucosamine phospholipid derivative inhibited the proliferation of C3H/HeJ cells stimulated by monophosphoryl lipid A or an Re glycolipid of E. coli. However, lipid A-associated protein activation of these cells was not inhibited, and optimal inhibition was observed when the inhibitors were added prior to the mitogens, suggesting competitive inhibition of a putative lipid A receptor (16) . More recently, Erwin et al. (3) reported that a nonmitogenic deacylated Neisseria meningitidis LPS blocked the mitogenic activity of Salmonella LPS in normal responder C3H/HeN spleen cells; however, this inhibition was also LPS specific and not observed with ConA-stimulated spleen cells. In our hands, the most efficient inhibitor has been the complete wild-type smooth LPS. Our preparations have been processed to remove nucleic acid and protein contaminants, neither of which are known as inhibitors in large or trace amounts. Indeed the protein isolated from smooth LPS of various species is well documented to be a potent polyclonal activator of B cells, surpassing LPS in some instances (12) . Therefore, we consider the LPS, and not trace contaminants, to be the active inhibitor. As to what may be responsible for this suppression, we have conducted numerous experiments, the results of which will be published later, that provide evidence that the major components of LPS can block C3H/HeJ splenic B-cell activation. Acid hydrolysis of LPS to produce free lipid A and polysaccharide revealed that both components can suppress the activation of C3H/HeJ cells but on a weight basis to a lesser extent than complete LPS. Even more intriguing has been the finding that mild alkaline hydrolysis of R595 LPS produces a material that can still activate LPS responder C3H/OuJ cells, cannot stimulate C3HIHeJ cells, but can act as an inhibitor of C3H/HeJ B-cell activation for DNA synthesis. It would appear then that lipid A molecules, which are microheterogeneous in structure (6), may have differing activities depending on the susceptibility of the cell or cell type used. In this regard, Kapp et al. (7) reported that R-form LPS and lipid A were more active in inducing human granulocyte oxygen radical production than smooth LPS and speculated that the presence of 0 polysaccharide in S-form LPS may have exerted an inhibitory effect on the granulocyte or the R-form LPS was more active because of its lipophilic character.
In our initial attempts to analyze the underlying features of this inhibitory effect, we examined the progression of stimulated B cells through the cell cycle by the use of cytofluorometry in the presence or absence of inhibiting concentrations of LPS. From the results obtained, it appears that many of the B cells were blocked from entry into Gl by LPS, whereas increasing numbers of EP-stimulated cells accumulated in Gl in the absence of LPS. As a consequence fewer EP-stimulated cells were found in S phase upon exposure to LPS, as was expected. Apparently signal events turned on relatively early in the cell cycle are affected by LPS. In addition, when B cells were stimulated by EP or by PMA and ionomycin for 12 h and then LPS was added, significant inhibition of DNA synthesis occurred as well (Fig. 2) . This suggests that after the initial signals have occurred, other biochemical events can be suppressed, rather than nonspecific effects such as the complexing of LPS with EP or PMA and ionomycin, which would prevent access of the stimulant to the cell surface. Candidates for such later events could be (i) RNA synthesis, which is compromised during the first 24 h of cell culture (Table 2) , or (ii) PKC activation, since specific PKC inhibitors can block PKC activation and subsequent DNA synthesis both early and 12 h after cells have been stimulated by EP or by PMA and ionomycin (1) .
The suppression phenomenon we have described is not meant to explain the lack of a mitotic response of C3H/HeJ B cells or macrophage activation. Rather C3HIHeJ cells still can be considered unreactive to LPS as a consequence of a genetic deficiency (11, 17) which most likely is due to lack of a signal receptor or the presence of a receptor which is incompetent in transducing the necessary signal. However, when the C3H/HeJ B cell receives a positive signal from an unrelated mitogen such as EP or PMA and ionomycin, exposure to LPS at relatively high concentrations turns on a negative signal(s) which blocks the cell from continuing through the cell cycle to proliferation. Although by their genetic nature, C3H/HeJ cells provide a system to study how LPS can suppress activated cells, there have been reports of LPS directly inhibiting other cells. At concentrations of LPS which are mitogenic for normal B cells, the continual proliferation of certain B-lymphoma cell lines can be blocked (9, 10) . In these studies the LPS was not cytotoxic, and growth resumed after LPS was removed; however, the stage of differentiation of the cell lines affected their susceptibility to the LPS effect. Thus, Ralph et al. (10) showed that R8 and RAW 112-2 are stem cell lines that were resistant to LPS, whereas RAW 8 and R7 pre-B cells were susceptible. Whether the signal pathway(s) affected by LPS in the B-lymphoma cells is similar to that presumed to occur in activated C3HIHeJ cells remains to be determined. Nevertheless, the comparison is intriguing and worthy of study.
Of additional interest is the fact that this suppression is not limited to B lymphocytes. T cells, thymocytes, and macrophages activated by various means can be inhibited by LPS. Since peritoneal macrophages are not known to proliferate, the biochemical events affected by LPS may differ from those which lead to B-cell or T-cell division. While this suggests that multiple signal pathways may be altered by LPS in C3H/HeJ cells it is also possible that a signal pathway common to both processes may be involved, such as PKC activation. Clearly, further studies are needed to delineate the mechanism of this suppression phenomenon. 
